Yabao Pharmaceutical Group Co. Ltd. announced that according to preliminary statistics of its financial department, the Company predicts a decrease of between RMB 248,340,000 and RMB 268,340,000 in its net profit owned by shareholders of the listed company in 2019 compared with the same period of the year before, a year-on-year decrease between 90.86% and 98.17% (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will decrease by between RMB 257,670,000 and RMB 277,670,000 compared with the same period of the year before, with a year-on-year decrease of between 100.61% and 108.42% (based on the disclosed statistics according to relevant regulations).